These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26866685)

  • 1. Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia.
    Dierickx S; Gryseels C; Mwesigwa J; O'Neill S; Bannister-Tyrell M; Ronse M; Jaiteh F; Gerrets R; D'Alessandro U; Grietens KP
    PLoS One; 2016; 11(2):e0148627. PubMed ID: 26866685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
    Mwesigwa J; Achan J; Affara M; Wathuo M; Worwui A; Mohammed NI; Kanuteh F; Prom A; Dierickx S; di Tanna GL; Nwakanma D; Bousema T; Drakeley C; Van Geertruyden JP; D'Alessandro U
    Clin Infect Dis; 2019 Jul; 69(2):278-286. PubMed ID: 30304511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.
    Fehr A; Nieto-Sanchez C; Muela J; Jaiteh F; Ceesay O; Maneh E; Baldeh D; Achan J; Dabira E; Conteh B; Bunders-Aelen J; Smekens T; Broekhuizen H; D'Alessandro U; Peeters Grietens K
    Malar J; 2021 Apr; 20(1):198. PubMed ID: 33902611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia.
    Jaiteh F; Masunaga Y; Okebe J; D'Alessandro U; Balen J; Bradley J; Gryseels C; Ribera JM; Grietens KP
    Malar J; 2019 Feb; 18(1):39. PubMed ID: 30777112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.
    Kajeechiwa L; Thwin MM; Shee PW; Yee NL; Elvina E; Peapah P; Kyawt K; Oo PT; PoWah W; Min JR; Wiladphaingern J; von Seidlein L; Nosten S; Nosten F
    Malar J; 2016 Sep; 15(1):494. PubMed ID: 27677694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia.
    Dial NJ; Ceesay SJ; Gosling RD; D'Alessandro U; Baltzell KA
    Malar J; 2014 Feb; 13():47. PubMed ID: 24495715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia.
    Okebe J; Dabira E; Jaiteh F; Mohammed N; Bradley J; Drammeh NF; Bah A; Masunaga Y; Achan J; Muela Ribera J; Yeung S; Balen J; Peeters Grietens K; D'Alessandro U
    Malar J; 2021 Jun; 20(1):253. PubMed ID: 34098984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Some anti-malarials are too strong for your body, they will harm you.' Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia.
    Jaiteh F; Dierickx S; Gryseels C; O'Neill S; D'Alessandro U; Scott S; Balen J; Grietens KP
    Malar J; 2016 Apr; 15():195. PubMed ID: 27068760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding adherence to reactive treatment of asymptomatic malaria infections in The Gambia.
    Jaiteh F; Okebe J; Masunaga Y; D'Alessandro U; Achan J; Gryseels C; de Vries D; Ribera JM; Grietens KP
    Sci Rep; 2021 Jan; 11(1):1746. PubMed ID: 33462329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.
    Tripura R; Peto TJ; Chea N; Chan D; Mukaka M; Sirithiranont P; Dhorda M; Promnarate C; Imwong M; von Seidlein L; Duanguppama J; Patumrat K; Huy R; Grobusch MP; Day NPJ; White NJ; Dondorp AM
    Clin Infect Dis; 2018 Aug; 67(6):817-826. PubMed ID: 29522113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing population-based mass drug administration for malaria: experience from a high transmission setting in North Eastern Uganda.
    Mulebeke R; Wanzira H; Bukenya F; Eganyu T; Collborn K; Elliot R; Van Geertruyden JP; Echodu D; Yeka A
    Malar J; 2019 Aug; 18(1):271. PubMed ID: 31399051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.
    Manning J; Lon C; Spring M; Wojnarski M; Somethy S; Chann S; Gosi P; Soveasna K; Sriwichai S; Kuntawunginn W; Fukuda MM; Smith PL; Rekol H; Sinoun M; So M; Lin J; Satharath P; Saunders D
    Trials; 2018 Oct; 19(1):558. PubMed ID: 30326952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial.
    Eisele TP; Silumbe K; Finn T; Chalwe V; Kamuliwo M; Hamainza B; Moonga H; Bennett A; Yukich J; Keating J; Steketee RW; Miller JM
    Trials; 2015 Aug; 16():347. PubMed ID: 26268804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
    Morris U; Msellem MI; Mkali H; Islam A; Aydin-Schmidt B; Jovel I; Shija SJ; Khamis M; Ali SM; Hodzic L; Magnusson E; Poirot E; Bennett A; Sachs MC; Tarning J; Mårtensson A; Ali AS; Björkman A
    BMC Med; 2018 Dec; 16(1):215. PubMed ID: 30526588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia.
    von Seidlein L; Walraven G; Milligan PJ; Alexander N; Manneh F; Deen JL; Coleman R; Jawara M; Lindsay SW; Drakeley C; De Martin S; Olliaro P; Bennett S; Schim van der Loeff M; Okunoye K; Targett GA; McAdam KP; Doherty JF; Greenwood BM; Pinder M
    Trans R Soc Trop Med Hyg; 2003; 97(2):217-25. PubMed ID: 14584381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
    Baiden R; Oduro A; Halidou T; Gyapong M; Sie A; Macete E; Abdulla S; Owusu-Agyei S; Mulokozi A; Adjei A; Sevene E; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Ogutu B; Upunda GL; Smith P; Binka F
    Malar J; 2015 Apr; 14():160. PubMed ID: 25885858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.
    Finn TP; Yukich JO; Bennett A; Porter TR; Lungu C; Hamainza B; Chizema Kawesha E; Conner RO; Silumbe K; Steketee RW; Miller JM; Keating J; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):19-27. PubMed ID: 32618251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
    Ewing VL; Terlouw DJ; Kapinda A; Pace C; Richards E; Tolhurst R; Lalloo DG
    Malar J; 2015 Jan; 14():13. PubMed ID: 25605477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.
    Bridges DJ; Miller JM; Chalwe V; Moonga H; Hamainza B; Steketee R; Silumbe K; Nyangu J; Larsen DA
    Trials; 2017 Nov; 18(1):511. PubMed ID: 29096671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos).
    Adhikari B; Phommasone K; Kommarasy P; Soundala X; Souvanthong P; Pongvongsa T; Henriques G; Newton PN; White NJ; Day NPJ; Dondorp AM; von Seidlein L; Mayxay M; Cheah PY; Pell C
    Malar J; 2018 Jan; 17(1):15. PubMed ID: 29316932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.